Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohorts.

Autor: Binks SNM; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.; Department of Neurology, John Radcliffe Hospital, Oxford, OX3 9DU, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK., Elliott KS; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK., Muñiz-Castrillo S; Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA 94304, USA., Gilbert E; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland.; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland., Kawasaki de Araujo T; Department of Translational Medicine, School of Medical Sciences, University of Campinas - UNICAMP, CEP 13083-888 - Campinas, Brazil., Harper AR; Clinical Development, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, UK., Brown AC; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK., Chong AY; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK., Band G; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK., Peris Sempere V; Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA 94304, USA., Pinto AL; French Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Costantino F; Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection et inflammation, Laboratory of Excellence INFLAMEX, France.; Rheumatology Department, APHP, Ambroise Paré Hospital, 92100, France., Rayner NW; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK.; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK.; Department of Human Genetics, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.; Institute of Translational Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, D-85764, Germany., Mentzer AJ; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK.; Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7BN, UK., Delanty N; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland.; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland., Rogemond V; French Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Picard G; French Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Handel AE; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.; Department of Neurology, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Melzer N; Department of Neurology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, 40204, Germany., Titulaer MJ; Department of Neurology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands., Lee ST; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, 03080, South Korea., Leypoldt F; Department of Neurology, University Hospital Schleswig-Holstein, Kiel, 24105, Germany.; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, 24105/Lübeck, 23538, Germany., Kuhlenbaeumer G; Department of Neurology, University Hospital Schleswig-Holstein, Kiel, 24105, Germany., Honnorat J; French Reference Centre for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Mignot E; Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA 94304, USA., Cavelleri GL; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Dublin 2, Ireland., Knight JC; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK., Irani SR; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.; Department of Neurosciences, Mayo Clinic, Jacksonville, FL 32224, USA.; Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.

Publikováno v: Brain : a journal of neurology [Brain] 2024 Oct 26. Date of Electronic Publication: 2024 Oct 26.

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis.

Autor: Binks SNM; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Veldsman M; Department of Experimental Psychology, University of Oxford, Oxford, UK., Handel AE; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Jacob S; Department of Neurology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Maddison P; Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK., Coebergh J; St Peter's Hospital, Ashford and St Peter's NHS Hospitals Foundation Trust, Chertsey, UK., Michael S; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Ramanathan S; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Translational Neuroimmunology Group, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Neurology, Concord Hospital, Sydney, New South Wales, Australia., Easton A; The Encephalitis Society, 32 Castlegate, Malton, North Yorkshire, YO17 7DT, UK.; Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK., Nissen MS; Department of Neurology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, DK-5000, Denmark., Leite MI; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Okai D; Neuropsychiatry Department, Maudsley Outpatients, Maudsley Hospital, Denmark Hill, London, SE5 8AZ, UK., Blaabjerg M; Department of Neurology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, DK-5000, Denmark., Husain M; Department of Experimental Psychology, University of Oxford, Oxford, UK.; Nuffield Department of Clinical Neurosciences, Oxford, UK., Irani SR; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Departments of Neurology and Neurosciences, Mayo Clinic, Jacksonville, Florida, USA.

Publikováno v: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 1053-1058. Date of Electronic Publication: 2024 Feb 01.

A feline model of spontaneously occurring autoimmune limbic encephalitis.

Autor: Glantschnigg-Eisl U; Clinic for Small Animals, Internal Medicine, University of Veterinary Medicine Vienna, Austria. Electronic address: Ursula.glantschnigg@vetklinikum.at., Klang A; Institute for Pathology and Forensic Veterinary Medicine, Universitiy of Veterinary Medicine Vienna, Austria., Kneissl S; Diagnostic Imaging, University of Veterinary Medicine Vienna, Austria., Lang B; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK., Waters P; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK., Irani SR; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK; Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals Foundation Trust, Oxford OX3 9DU, UK., Binks SNM; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK; Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals Foundation Trust, Oxford OX3 9DU, UK., Pakozdy A; Clinic for Small Animals, Internal Medicine, University of Veterinary Medicine Vienna, Austria.

Publikováno v: Veterinary journal (London, England : 1997) [Vet J] 2023 Jun-Jul; Vol. 296-297, pp. 105974. Date of Electronic Publication: 2023 Mar 21.

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.

Autor: Binks SNM; Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.; Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK., Klein CJ; Department of Neurology, Neuroimmunology Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Waters P; Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.; Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK., Pittock SJ; Department of Neurology, Neuroimmunology Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Irani SR; Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.; Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK.

Publikováno v: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2018 May; Vol. 89 (5), pp. 526-534. Date of Electronic Publication: 2017 Oct 21.